Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase NA 6Phase 1/2 6Phase 1 6Phase 3 4Phase 4 1Phase 2/3 1

Status

Completed 58Terminated 13Unknown 6Recruiting 5Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

NET 2Endocrine 2Breast 2Gastrointestinal 1

Conditions

Neuroendocrine Tumors 2Triple Negative Breast Neoplasms 1Metatropic dwarfism 1Carcinoma, Hepatocellular 1Carcinoid Tumor 1Breast Neoplasms 1Advanced Malignancies 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 27Cisplatin 27Carboplatin 27Capecitabine 27camrelizumab 24Nivolumab 23apatinib 22Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 17Immunotherapy, Adoptive 17Drug Therapy 17pembrolizumab 16Docetaxel 16Dexamethasone 15Bevacizumab 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12130-nm albumin-bound paclitaxel 11anlotinib 10Fluorouracil 10Trastuzumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Everolimus × Clear all
NCT03805399 2022-08-10

FUTURE

Fudan University

Phase 1/2 Unknown
140 enrolled
Breast

Triple Negative Breast Neoplasms

NCT03629847 2018-08-14

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

King Faisal Specialist Hospital & Research Center

Phase 1/2 Unknown
30 enrolled
EndocrineNET

Metatropic dwarfism, Neuroendocrine Tumors

NCT00930475 2011-01-26

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer

Charite University, Berlin, Germany

Phase 1/2 Unknown
54 enrolled
Breast

Breast Neoplasms

NCT01175096 2010-08-04

Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

Guangdong Provincial People's Hospital

Phase 1/2 Unknown
20 enrolled
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT01079702 2010-03-03

m-TOR

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Unknown
35 enrolled

Advanced Malignancies

NCT00390195 2009-07-02

Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)

National Health Research Institutes, Taiwan

Phase 1/2 Unknown
134 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡